BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 24678737)

  • 1. Resistant hypertension: is renal denervation the current treatment of choice?
    Reddi AS
    Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
    Hering D; Esler MD; Schlaich MP
    EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation: transition from pathophysiology to clinical practice.
    Gossios TD; Ziakas A; Doumas M; Katsiki N; Petroglou D; Kouparanis A; Lillis L; Karvounis H
    Angiology; 2014 Oct; 65(9):760-8. PubMed ID: 24402321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal sympathetic denervation in hypertension.
    Doumas M; Faselis C; Papademetriou V
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal denervation for resistant hypertension and beyond.
    Laffin LJ; Bakris GL
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):133-9. PubMed ID: 25704350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation: current implications and future perspectives.
    Xu J; Hering D; Sata Y; Walton A; Krum H; Esler MD; Schlaich MP
    Clin Sci (Lond); 2014 Jan; 126(1):41-53. PubMed ID: 24020446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R; Hinderliter AL
    Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation: a plea for wisdom.
    Lantelme P; Courand PY; Pathak A
    Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of resistant hypertension in chronic kidney disease.
    Campese VM
    Semin Nephrol; 2014; 34(5):571-6. PubMed ID: 25416666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response and non-response to renal denervation: who is the ideal candidate?
    Ukena C; Cremers B; Ewen S; Böhm M; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R54-7. PubMed ID: 23732156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA;
    Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal nerve ablation for hypertensive patients with chronic kidney disease.
    Papademetriou V; Doumas M; Anyfanti P; Faselis C; Kokkinos P; Tsioufis C
    Curr Vasc Pharmacol; 2014 Jan; 12(1):47-54. PubMed ID: 23905594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.
    McArdle MJ; deGoma EM; Cohen DL; Townsend RR; Wilensky RL; Giri J
    J Am Heart Assoc; 2015 Mar; 4(3):e001415. PubMed ID: 25801757
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.